Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations

Zahra Goudarzi, Mohsen Ghafari Darab,Afsaneh Vazin,Amirreza Hayatbakhsh,Iman Karimzadeh,Mojtaba Jafari,Khosro Keshavarz,Afshin Borhani-Haghighi

Value in Health Regional Issues（2023）

引用 1|浏览8

暂无评分

摘要

Despite the differences and variations in the economic evaluation studies of NOAC drugs, these drugs have shown acceptable cost-effectiveness in developed and developing countries. Among NOAC drugs, apixaban has the lowest ICER and the highest cost-effectiveness.

查看译文

关键词

atrial fibrillation,economic evaluation,oral anticoagulants,stroke prevention,systematic review

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要